Figure 1.
Impact of SARS-CoV-2 mRNA vaccination on receptor antibodies in healthy controls. Levels of GPCR antibodies in the sera of healthy volunteers (N = 89) six months after 2nd vaccination with Spikevax (Moderna) expressed as % of corresponding values obtained immediately before 1st vaccination. Boxes and error bars: medians ± interquartile ranges of significant changes (paired t-test, p < 0.0001).